The SoS trial
Nashef, S.A.M.; Jenkins, D.P.
Lancet 361(9357): 615; Author Reply 616
2003
ISSN/ISBN: 0140-6736 PMID: 12598173 Document Number: 560419
Document emailed within 1 workday
Related Documents
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Gotto, A.M. 1997: The Multiple Risk Factor Intervention Trial (MRFIT). a return to a landmark trial JAMA 277(7): 595-597
Mahé, E.; Sachwald, J.; Brunet, M.; Clavel, B.; Debaud, B.; Meeus, L. 1978: Immune therapy trial with Corynebacterium in patients with E.N.T. cancer. (Code name of the trial: "Reticulo-stimuline") Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 95(9): 629-635
1990: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group JAMA 263(13): 1795-1801
Bakari, M.; Munseri, P.; Francis, J.; Aris, E.; Moshiro, C.; Siyame, D.; Janabi, M.; Ngatoluwa, M.; Aboud, S.; Lyamuya, E.; Sandström, E.; Mhalu, F. 2013: Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/Ii HIVIS 03 trial Bmc Public Health 13: 1149
Nilsson, P. 2003: Conclusions in an Australian trial differ from those in the ALLHAT trial: ACE inhibitors are more effective than thiazides in elderly men with hypertension Lakartidningen 100(13): 1118-1120
Evans, S.; Pocock, S. 2001: Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial Bmj 322(7286): 569-570
Ndebele, P.M.; Wassenaar, D.; Munalula, E.; Masiye, F. 2012: Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi Bmc Medical Ethics 13: 29
Suzuki, S. 1979: Status of the pre-trial psychiatric tests represented in the Akabori trial Seishin Shinkeigaku Zasshi 81(4): 259-273
Altman, D.; Carroli, G.; Duley, L.; Farrell, B.; Moodley, J.; Neilson, J.; Smith, D. 2002: Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial Lancet 359(9321): 1877-1890
Mantero, J.C.; Kishore, N.; Ziemek, J.; Stifano, G.; Zammitti, C.; Khanna, D.; Gordon, J.K.; Spiera, R.; Zhang, Y.; Simms, R.W.; Lafyatis, R. 2018: Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. a phase I/Ii biomarker trial Clinical and Experimental Rheumatology 36 Suppl 113(4): 146-149
Brener, S.J.; Midei, M.G.; Nukta, D.; Kereiakes, D.J.; Rizik, D.G.; Murphy, D.; Brennan, D.; Moliterno, D.J. 2003: A randomized multicenter trial comparing a new, low-pressure versus a conventional coronary stent: primary results from the CONSERVE trial Journal of Invasive Cardiology 15(3): 128-132
Ohnuma, A.; Seki, H.; Fujii, T.; Ogawa, T.; Kimura, I. 1994: Event related potentials and reaction time on auditory discrimination tasks (2nd report)--a study by trial-to-trial analysis Rinsho Shinkeigaku 34(1): 5-11
Murnane, P.M.; Brown, E.R.; Donnell, D.; Coley, R.Yates.; Mugo, N.; Mujugira, A.; Celum, C.; Baeten, J.M.; Mujugira, A.; Baeten, J.M.; Murnane, P.M.; Donnell, D.; Mugo, N.; Brown, E.R.; Yates Coley, R.; Celum, C.; Coombs, R.W.; Frenkel, L.; Hendrix, C.W.; Lingappa, J.; Juliana McElrath, M.; Fife, K.; Were, E.; Tumwesigye, E.; Ndase, P.; Katabira, E.; Ronald, A.; Bukusi, E.; Cohen, C.; Wangisi, J.; Campbell, J.; Tappero, J.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Mugo, N.Rwamba. 2015: Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention American Journal of Epidemiology 182(10): 848-856
Lindsey, J.C.; Shah, S.K.; Siberry, G.K.; Jean-Philippe, P.; Levin, M.J. 2013: Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings Developing World Bioethics 13(2): 95-104
Locker, G.Y.; Khandekar, J.; Krauss, S.; Reisel, H.; Hoeltgen, T.; Wolter, J.; Haid, M.; Hoffman, R.; Blough, R.; Johnson, C. 1987: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial Cancer Treatment Reports 71(6): 649-650
Baumann, L.; Goldberg, D.J.; Stein Gold, L.; Tanghetti, E.A.; Lain, E.; Kaufman, J.; Weng, E.; Berk, D.R.; Ahluwalia, G. 2018: Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated with Rosacea: Findings from the Second REVEAL Trial Journal of Drugs in Dermatology: Jdd 17(3): 290-298
Kramer, M.S.; Chalmers, B.; Hodnett, E.D.; Sevkovskaya, Z.; Dzikovich, I.; Shapiro, S.; Collet, J.P.; Vanilovich, I.; Mezen, I.; Ducruet, T.; Shishko, G.; Zubovich, V.; Mknuik, D.; Gluchanina, E.; Dombrovsky, V.; Ustinovitch, A.; Ko, T.; Bogdanovich, N.; Ovchinikova, L.; Helsing, E. 2000: Promotion of breastfeeding intervention trial (PROBIT): a cluster-randomized trial in the Republic of Belarus. Design, follow-up, and data validation Advances in Experimental Medicine and Biology 478: 327-345
Kircik, L.H.; DuBois, J.; Draelos, Z.D.; Werschler, P.; Grande, K.; Cook-Bolden, F.E.; Weng, E.; Berk, D.R.; Ahluwalia, G. 2018: Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated with Rosacea: Findings from the first REVEAL Trial Journal of Drugs in Dermatology: Jdd 17(1): 97-105